Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macula; Degeneration”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)Looking for participantsNCT06659549
What this trial is testing

Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Who this might be right for
Geographic Atrophy of the Macula
Galimedix Therapeutics Inc 110
Not applicableUnknownNCT06349304
What this trial is testing

Impact of Grape Powder Consumption on Eye Health and Glycemic Status in Singapore Older Adults

Who this might be right for
Macula; DegenerationAgingAdvanced Glycation End Products
National University of Singapore 46
Large-scale testing (Phase 3)Study completedNCT04047472
What this trial is testing

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 397
Testing effectiveness (Phase 2)Study completedNCT01284478
What this trial is testing

Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery

Who this might be right for
Pseudophakic Cystoid Macular Edema,Diabetic Macular Edema
Northern California Retina Vitreous Associates 6
Not applicableStudy completedNCT06878573
What this trial is testing

Change in Ocular Perfusion After Intravitreal Anti-VEGF in Patients with Age-related Maculopathy or Diabetic Macula Edema

Who this might be right for
Age Related Macular DegenerationDiabetic Macular Edema
Augenabteilung Allgemeines Krankenhaus Linz 36
Not applicableStudy completedNCT05208879
What this trial is testing

CArotenoid in hypoChOlesterolemia

Who this might be right for
Primary Intestinal HypocholesterolemiaAbetalipoproteinemiaChylomicron Retention Disease
Hospices Civils de Lyon 10
Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Not applicableUnknownNCT05056025
What this trial is testing

Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration.

Who this might be right for
AMDSoft DrusenReticular Pseudodrusen+2 more
Institut de la Macula y la Retina 48
Not applicableActive Not RecruitingNCT01115387
What this trial is testing

GARM II: A Study on the Genetics of Age-related Maculopathy

Who this might be right for
Age-related Macular DegenerationAge-related Maculopathy
University of California, Los Angeles 603
Large-scale testing (Phase 3)Study completedNCT00523406
What this trial is testing

Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)

Who this might be right for
Macular Degeneration
Medical University of Vienna 40
Not applicableUnknownNCT04882956
What this trial is testing

BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration

Who this might be right for
Macula Lutea Degeneration
Benha University 40
Testing effectiveness (Phase 2)Study completedNCT00390208
What this trial is testing

Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Bay Area Retina Associates 60
Not applicableStudy completedNCT01363570
What this trial is testing

Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes

Who this might be right for
Age Related Macular Degeneration
McMaster University 70
Not applicableStudy completedNCT03150654
What this trial is testing

The Effect of Laser Treatment on Macular Pigment of Eye in Cases With Diabetes

Who this might be right for
Diabetic RetinopathyRetinal DegenerationMacula Abnormality+1 more
Afyon Kocatepe University Hospital 36
Not applicableStudy completedNCT03278262
What this trial is testing

The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical Setting

Who this might be right for
Wet Macular Degeneration
Bayer 2,312
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Post-approval studies (Phase 4)Looking for participantsNCT06875245
What this trial is testing

Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals

Who this might be right for
Wet Age-related Macular Degeneration
Faculty Hospital Kralovske Vinohrady 100
Not applicableStudy completedNCT01603823
What this trial is testing

Angiographie and OCT in Macula and Retinal Diseases

Who this might be right for
Macular Edema
Medical University of Vienna 30
Testing effectiveness (Phase 2)Study completedNCT03927690
What this trial is testing

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 91
Large-scale testing (Phase 3)Study completedNCT04005352
What this trial is testing

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 734
Next Page